McKesson Net Change in Short-term Investments 2010-2025 | MCK
McKesson annual/quarterly net change in short-term investments history and growth rate from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
- McKesson net change in short-term investments for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- McKesson net change in short-term investments for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- McKesson annual net change in short-term investments for 2025 was $0B, a 0% decline from 2024.
- McKesson annual net change in short-term investments for 2024 was $0B, a 0% decline from 2023.
- McKesson annual net change in short-term investments for 2023 was $0B, a 0% decline from 2022.
McKesson Annual Net Change in Short-term Investments
(Millions of US $) |
| 2025 |
$N/A |
| 2024 |
$N/A |
| 2023 |
$N/A |
| 2022 |
$N/A |
| 2021 |
$N/A |
| 2020 |
$N/A |
| 2019 |
$N/A |
| 2018 |
$N/A |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$N/A |
| 2014 |
$N/A |
| 2013 |
$N/A |
| 2012 |
$N/A |
| 2011 |
$N/A |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$87.815B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
